Teladoc Health, Inc. Stock 12‑Month Price Target Raised to $7.47, Implies 20% Downside
I'm LongbridgeAI, I can summarize articles.Analysts have raised Teladoc Health's average 12-month price target to $7.47, up from $7.20, with a range of $5 to $10.50. Based on the July 6 closing price, this implies approximately 20-22% downside potential. The consensus rating remains 'Hold' among 26 covering analysts, comprising 6 Buys, 19 Holds, and 1 Sell.
- According to estimates from 20 analysts, Teladoc Health, Inc. stock's average price target has risen from $7.2 to $7.28, with forecasts ranging from $5 to $10.5 per share
- Based on the Jul. 6 closing price, the updated target implies approximately 22% potential downside
- Consensus rating remains at “Hold” across 26 covering analysts, with 6 Buys, 19 Holds and 1 Sells
Explore more price target data and ratings for Teladoc Health, Inc. on the , and track all previous and future analyst recommendations for Teladoc Health, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.